Gastrointestinal involvement in systemic vasculitis occurs in up to 30% of patients. Fortunately intestinal infarction is a rare complication, but if present carries a high mortality, and swift management of the underlying vasculitis is crucial. Two such cases are described.
GuillevinLHuongDTLGodernPJaisPWechslerB.Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: A study of.165 patients. Br J Rheumatol1988; 27: 258–64
2.
LopezLRSchocketALStandfordREClamanHNKohlerPF. Gastrointestinal involvement in leucocytoclastic vasculitis and polyarteritis nodosa. J Rheumatol1980; 7: 677–84
3.
ScottDGIBaconPAElliottPJTribeCRWallingtonTB. Systemic vasculitis in a district general hospital 1972–1980: Clinical and laboratory features, classification and prognosis of 80 cases. QJ Med1982; 203: 292–311
4.
ColtonCLButlerTJ. The surgical problem of polyarteritis nodosa. Br J Surg1967; 54: 393–6
5.
FauciASKatzPHaynesBFWolffSM. Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med1979; 301: 235–8
6.
ScottDGIBaconPA. Intravenous cyclophosphamide and methylprednisolone in the treatment of systemic rheumatoid vasculitis. Am J Med1984; 76: 377–84
7.
GuillevinLOJarrouseBLokC, Long term follow-up after treatment of polyarteritis nodosa and Churg-Strauss angiitis, with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. J Rheumatol1991; 18: 567–74
